These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34345035)

  • 41. Strategic groups in the biopharmaceutical industry: implications for performance.
    Erden Z; von Krogh G; Nytorp C; Hultberg M
    Drug Discov Today; 2009 Aug; 14(15-16):726-30. PubMed ID: 19416760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An audience with...Francis Collins. Interviewed by Asher Mullard.
    Collins F
    Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug discovery management, small is still beautiful: Why a number of companies get it wrong.
    Knutsen LJ
    Drug Discov Today; 2011 Jun; 16(11-12):476-84. PubMed ID: 21504798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Big pharma craves slice of AI-based RNA drug discovery.
    Nat Biotechnol; 2023 Mar; 41(3):305. PubMed ID: 36922694
    [No Abstract]   [Full Text] [Related]  

  • 45. Market failure in the pharmaceutical industry and how it can be overcome: the CureShare mechanism.
    Levy M; Rizansky A
    Eur J Health Econ; 2014 Mar; 15(2):143-56. PubMed ID: 23417217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
    Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
    Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mads Krogsgaard Thomsen. Interview by Asher Mullard.
    Thomsen MK
    Nat Rev Drug Discov; 2014 Feb; 13(2):96-7. PubMed ID: 24481301
    [No Abstract]   [Full Text] [Related]  

  • 48. Out-licensing role reversal.
    Morrison C
    Nat Rev Drug Discov; 2017 Mar; 16(3):151-152. PubMed ID: 28248940
    [No Abstract]   [Full Text] [Related]  

  • 49. A new application of value-stream mapping in new drug development: a case study within Novartis.
    Heinzen M; Mettler S; Coradi A; Boutellier R
    Drug Discov Today; 2015 Mar; 20(3):301-5. PubMed ID: 25448754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mergers and innovation in the pharmaceutical industry.
    Comanor WS; Scherer FM
    J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dilemma over AI and drug patenting already under debate.
    King RD; Courtney P
    Nature; 2018 Aug; 560(7718):307. PubMed ID: 30108355
    [No Abstract]   [Full Text] [Related]  

  • 52. Academic drug discovery: current status and prospects.
    Everett JR
    Expert Opin Drug Discov; 2015; 10(9):937-44. PubMed ID: 26088126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons.
    Kp Jayatunga M; Ayers M; Bruens L; Jayanth D; Meier C
    Drug Discov Today; 2024 Jun; 29(6):104009. PubMed ID: 38692505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advancing Drug Discovery via Artificial Intelligence.
    Chan HCS; Shan H; Dahoun T; Vogel H; Yuan S
    Trends Pharmacol Sci; 2019 Aug; 40(8):592-604. PubMed ID: 31320117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How to help the free market fight coronavirus.
    Burley SK
    Nature; 2020 Apr; 580(7802):167. PubMed ID: 32210376
    [No Abstract]   [Full Text] [Related]  

  • 56. Compound Passport Service: supporting corporate collection owners in open innovation.
    Andrews DM; Degorce SL; Drake DJ; Gustafsson M; Higgins KM; Winter JJ
    Drug Discov Today; 2015 Oct; 20(10):1250-5. PubMed ID: 26136162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hunting for New Drugs with AI.
    Freedman DH
    Nature; 2019 Dec; 576(7787):S49-S53. PubMed ID: 31853074
    [No Abstract]   [Full Text] [Related]  

  • 58. Driving drug discovery and patient therapy via the encapsulation and fusion of knowledge.
    Collins MA; Shaw I; Billington DC
    Drug Des Discov; 1999 Nov; 16(3):181-94. PubMed ID: 10624564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ChatGPT or LLM in next-generation drug discovery and development: pharmaceutical and biotechnology companies can make use of the artificial intelligence-based device for a faster way of drug discovery and development.
    Pal S; Bhattacharya M; Islam MA; Chakraborty C
    Int J Surg; 2023 Dec; 109(12):4382-4384. PubMed ID: 37707542
    [No Abstract]   [Full Text] [Related]  

  • 60. Crowdsourcing in pharma: a strategic framework.
    Bentzien J; Bharadwaj R; Thompson DC
    Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.